Filing Flows › Caribou Biosciences (CRBU) › Recalls, complaints & regulation
Caribou Biosciences (CRBU): clinical trials
Caribou Biosciences (CRBU) beyond its filings: 3 active clinical trials.
Caribou Biosciences' latest quarter
Caribou Biosciences, Q3 2026: revenue $1.6M (-27% year over year), net loss $26.6M, operating cash flow −$22.5M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Caribou Biosciences have?
3 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.